全文获取类型
收费全文 | 738篇 |
免费 | 82篇 |
国内免费 | 1篇 |
专业分类
821篇 |
出版年
2021年 | 9篇 |
2019年 | 8篇 |
2018年 | 7篇 |
2017年 | 8篇 |
2016年 | 7篇 |
2015年 | 19篇 |
2014年 | 19篇 |
2013年 | 26篇 |
2012年 | 33篇 |
2011年 | 33篇 |
2010年 | 17篇 |
2009年 | 21篇 |
2008年 | 25篇 |
2007年 | 22篇 |
2006年 | 20篇 |
2005年 | 16篇 |
2004年 | 10篇 |
2003年 | 15篇 |
2002年 | 21篇 |
2001年 | 9篇 |
2000年 | 19篇 |
1999年 | 12篇 |
1998年 | 10篇 |
1997年 | 12篇 |
1996年 | 7篇 |
1994年 | 9篇 |
1993年 | 12篇 |
1992年 | 15篇 |
1991年 | 10篇 |
1990年 | 18篇 |
1989年 | 16篇 |
1988年 | 13篇 |
1987年 | 22篇 |
1986年 | 19篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 13篇 |
1982年 | 15篇 |
1981年 | 11篇 |
1980年 | 12篇 |
1979年 | 16篇 |
1977年 | 14篇 |
1976年 | 10篇 |
1974年 | 9篇 |
1973年 | 7篇 |
1971年 | 16篇 |
1970年 | 9篇 |
1967年 | 7篇 |
1944年 | 8篇 |
1943年 | 6篇 |
排序方式: 共有821条查询结果,搜索用时 6 毫秒
91.
92.
93.
mtDNA mutations that cause optic neuropathy: how do we know? 总被引:4,自引:1,他引:3
N Howell C Bogolin R Jamieson D R Marenda D A Mackey 《American journal of human genetics》1998,62(1):196-202
94.
Identification of glycoprotein IV (CD36) as a primary receptor for platelet-collagen adhesion 总被引:23,自引:0,他引:23
The role of glycoprotein IV (GPIV) in platelet activation processes has been examined by several different approaches: (i) Fab fragments of a monospecific polyclonal antibody to purified platelet GPIV (approximately 20 micrograms/ml) completely inhibited platelet shape change, aggregation, and secretion induced by collagen. Aggregation and secretion by ADP (but not shape change) and by epinephrine were also inhibited, but there was no effect on platelet activation induced by thrombin, arachidonate, or ionophore A23187. (ii) Purified GPIV was able to compete completely with membrane-bound GPIV to inhibit platelet activation induced by collagen, including shape change, but not in activation induced by any of the other platelet agonists. 50% inhibition of collagen-induced activation and secretion were obtained at GPIV concentrations of approximately 10 nM (1 micrograms/ml). (iii) Purified GPIV bound rapidly and reversibly to collagen Type I fibrils, and binding was not inhibited by adhesive proteins such as denatured collagen, fibronectin, fibrinogen, or von Willebrand factor. The direct binding of purified GPIV to collagen Type I fibrils fit best to a single site model with Kd 0.34 +/- 0.10 nM. (iv) Using a microtiter assay, platelet adhesion to collagen was shown to be inhibited by Fab fragments of monospecific polyclonal anti-GPIV antibodies, but adhesion to other adhesive proteins was unaffected. (v) When anti-GPIV was added at various times during adhesion the time dependence of inhibition was seen to be biphasic. Anti-GP antibody was able to reverse adhesion that occurred within the first 5-8 min and to inhibit adhesion occurring thereafter. These results demonstrate that GPIV mediates the early stages of platelet recognition by and attachment to collagen but that there may be a second GPIV-independent mechanism that mediates the subsequent anchorage of these adherent platelets. 相似文献
95.
96.
97.
98.
The consequences of active site mutations of the Escherichia coli D-xylose isomerase (E.C. 5.3.1.5) on substrate binding were examined by fluorescence spectroscopy. Site-directed mutagenesis of conserved tryptophan residues in the E. coli enzyme (Trp49 and Trp188) reveals that fluorescence quenching of these residues occurs during the binding of xylose by the wild-type enzyme. The fluorescent properties of additional active site substitutions at His101 were also examined. Substitutions of His101 which inactivate the enzyme were shown to have altered spectral characteristics, which preclude detection of substrate binding. In the case of H101S, a mutant protein with measurable isomerizing activity, substrate binding with novel fluorescent properties was observed, possibly the bound pyranose form of xylose under steady-state conditions. 相似文献
99.
100.